| Code | 5127B | ||||||||||
| MA number | 15/0282/15-S | ||||||||||
| Product Form: | plo ijf 5x1 g (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | MIP Pharma GmbH, Germany | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.07.2015 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Ceftazidim MIP plo ijf_02.2021.doc
|
| SPC: |
SPC_Ceftazidim MIP plo ijf_02.2021.doc
|
| Safety feature | Yes |
| Data update: | 12.02.2021 |
